$90.96
0.49% yesterday
Nasdaq, Nov 25, 10:03 pm CET
ISIN
US5165441032
Symbol
LNTH

Lantheus Holdings Inc Stock price

$90.96
-19.34 17.53% 1M
+12.74 16.29% 6M
+28.96 46.71% YTD
+19.97 28.13% 1Y
+62.58 220.51% 3Y
+70.26 339.42% 5Y
+84.19 1,243.57% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.44 0.49%
ISIN
US5165441032
Symbol
LNTH
Sector

Key metrics

Market capitalization $6.32b
Enterprise Value $6.08b
P/E (TTM) P/E ratio 15.11
EV/FCF (TTM) EV/FCF 13.45
EV/Sales (TTM) EV/Sales 4.06
P/S ratio (TTM) P/S ratio 4.23
P/B ratio (TTM) P/B ratio 5.46
Revenue growth (TTM) Revenue growth 24.15%
Revenue (TTM) Revenue $1.50b
EBIT (operating result TTM) EBIT $474.44m
Free Cash Flow (TTM) Free Cash Flow $451.98m
Cash position $866.39m
EPS (TTM) EPS $6.02
P/E forward 15.80
P/S forward 4.16
EV/Sales forward 4.00
Short interest 7.94%
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Lantheus Holdings Inc forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
92%
Hold
8%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,497 1,497
24% 24%
100%
- Direct Costs 527 527
25% 25%
35%
970 970
24% 24%
65%
- Selling and Administrative Expenses 283 283
41% 41%
19%
- Research and Development Expense 150 150
55% 55%
10%
537 537
114% 114%
36%
- Depreciation and Amortization 62 62
10% 10%
4%
EBIT (Operating Income) EBIT 474 474
145% 145%
32%
Net Profit 428 428
311% 311%
29%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
The Motley Fool
6 days ago
Why Lantheus Holdings Stock Won Big on Wednesday
Neutral
GlobeNewsWire
6 days ago
BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its board of directors has authorized a program to repurchase up to $250 million of its common stock during the nex...
Neutral
GlobeNewsWire
13 days ago
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 1:00 p.m. GM...
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 834
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today